Publication Details

Category Text Publication
Reference Category Journals
DOI 10.1152/ajplung.00110.2006
Title (Primary) Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin
Author Laudi, S.; Trump, S.; Schmitz, V.; West, J.; McMurtry, I.F.; Mutlak, H.; Christians, U.; Weimann, J.; Kaisers, U.; Steudel, W.
Source Titel American Journal of Physiology-Lung Cellular and Molecular Physiology
Year 2007
Department IMMU
Volume 293
Issue 3
Page From L630
Page To L638
Language englisch
Keywords monocrotaline; HMG-CoA-reductase inhibitor, 5-HTT, 5-HT
Abstract HMG-CoA-reductase inhibitors (statins) influence lipid metabolism and have pleiotropic effects. Several statins reduce various forms of pulmonary hypertension (PH) in animal models. The relationship between atorvastatin and expression of serotonin transporter protein (5-HTT) remains unknown. This study focused on the effects of atorvastatin on the course of monocrotaline (MCT)-induced PH and its relation to 5-HTT expression. Male Sprague-Dawley rats were challenged with MCT with or without subsequent daily oral treatment with 0.1, 1, and 10 mg/kg of atorvastatin for 28 days. Over the 4-wk course, the progression of PH was followed by transthoracic echocardiography [pulmonary artery pressure was assessed by pulmonary artery flow acceleration time (PAAT), an estimate reciprocal to pulmonary artery pressure], and, at the end of the 4-wk course, invasive right ventricular pressure, right ventricular weight, quantitative morphology, and 5-HTT expression were measured. MCT caused significant PH as early as 7 days after injection. Atorvastatin treatment increased PAAT and reduced right ventricular pressure, right ventricular hypertrophy, and vascular remodeling over the 4-wk course. MCT challenge was associated with increased pulmonary vascular 5-HTT expression, and atorvastatin treatment reduced the 5-HTT expression. MCT-induced PH over the course of 4 wk can be easily followed by transthoracic echocardiography, and atorvastatin is effective in reducing the PH. Atorvastatin's effects are associated with a decrease of 5-HTT expression.
Persistent UFZ Identifier
Laudi, S., Trump, S., Schmitz, V., West, J., McMurtry, I.F., Mutlak, H., Christians, U., Weimann, J., Kaisers, U., Steudel, W. (2007):
Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin
Am. J. Physiol.-Lung Cell. Mol. Physiol. 293 (3), L630 - L638 10.1152/ajplung.00110.2006